You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune Reconstitution

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Reconstitution After Allo-HSCT and Blinatumomab

Not yet recruiting
  • Leukemia, Lymphoid
  • (no location specified)
Oct 3, 2023

Immune Reconstitution to CMV After HSCT: Impact of Clinical

Enrolling by invitation
  • CMV Infection
  • Hematopoietic Stem Cell Transplantation
  • Beijing, Beijing, China
  • +1 more
Jan 5, 2023

HIV Trial in Cincinnati (Truvada (tenofovir/emtricitabine), Kaletra (lopinavir/ritonavir))

Completed
Has Results
  • HIV Infections
  • Truvada (tenofovir/emtricitabine)
  • Kaletra (lopinavir/ritonavir)
  • Cincinnati, Ohio
    University of Cincinnati AIDS Clinical Trials Unit
Jul 14, 2022

Progressive Multifocal Leukoencephalopathy Trial run by the NINDS (NT-I7)

Recruiting
  • Progressive Multifocal Leukoencephalopathy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 2, 2022

AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)

Recruiting
  • AIDS Virus
  • Disorder of Immune Reconstitution
  • normal saline
  • Mesenchymal stem cells
  • Jinan, Shandong, China
    Shandong Public Health Clinical Center
May 14, 2023

HIV-1-infection Trial in Shanghai (Zadaxin)

Recruiting
  • HIV-1-infection
  • Shanghai, Shanghai, China
    Fudan University
Sep 5, 2021

Kaposi Sarcoma, Human Immunodeficiency Virus, Immune Reconstitution Syndrome Trial in Mexico city (Valganciclovir,

Completed
Has Results
  • Kaposi Sarcoma
  • +2 more
  • Mexico city, Mexico
    Instituto Nacional de Cancerologia
Nov 23, 2021

Breast Carcinoma, Colorectal Adenocarcinoma, Bladder Carcinoma Trial run by the National Cancer Institute (NCI) (Recombinant

Recruiting
  • Breast Carcinoma
  • +2 more
  • Recombinant human IL-7-hyFc (NT-I7)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Reconstitution ofHuman Immune System inPatient Derived Xenograft

Suspended
  • Genito Urinary Cancer
  • +3 more
  • Bone marrow biopsy
  • Tumor biopsy
  • Durham, North Carolina
    Duke University Medical Center
Nov 17, 2022

Immunodeficiency Trial in Charlotte (Infusion of donor lymphocytes)

Terminated
Has Results
  • Immunodeficiency
  • Infusion of donor lymphocytes
  • Charlotte, North Carolina
    Levine Children's Hospital, Carolinas Medical Center
Apr 20, 2022

Solid Tumor Malignancies Trial in Houston (Autologous lymphocyte infusion (ALI))

Recruiting
  • Solid Tumor Malignancies
  • Autologous lymphocyte infusion (ALI)
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

HIV Trial in Baltimore (Lopinavir/Ritonavir)

Terminated
Has Results
  • HIV
  • Baltimore, Maryland
    University of Maryland, Institute of Human Virology
Jan 20, 2022

Pediatric Cancer Trial in Manchester (Granulocytes)

Recruiting
  • Pediatric Cancer
  • Granulocytes
  • Manchester, United Kingdom
    Royal Manchester Childrens Hospital, MFT
Jun 17, 2022

Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus) Trial in Pessac, Paris (Human T Lymphoid Progenitor (HTLP)

Recruiting
  • Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus)
  • Human T Lymphoid Progenitor (HTLP) injection
  • Pessac, France
  • +1 more
Oct 28, 2021

HIV-1 Infection Trial in Toulouse (Peripheral blood and intestinal biopsies will be collected)

Completed
  • HIV-1 Infection
  • Peripheral blood and intestinal biopsies will be collected
  • Toulouse, France
  • +1 more
Dec 30, 2021

Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), MDS (MDS) Trial in New York (other, radiation, drug)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Personalized rATG (P-rATG)
  • +7 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 31, 2022

Leukemia, Acute Trial in New York (Allogeneic T cell progenitors, cultured ex-vivo)

Recruiting
  • Leukemia, Acute
  • Allogeneic T cell progenitors, cultured ex-vivo
  • New York, New York
    Memorial Sloan Kettering Cancer Center (MSKCC)
Dec 9, 2021

Hodgkin Disease Trial in Houston (ABVE-PC, DECA)

Active, not recruiting
  • Hodgkin Disease
  • Houston, Texas
    Texas Children's Hospital
Jan 19, 2022

Inflammation in HIV Infection Trial in Los Angeles (arabinoxylan rice bran, Placebo for arabinoxylan rice bran)

Completed
  • Inflammation in HIV Infection
  • arabinoxylan rice bran
  • Placebo for arabinoxylan rice bran
  • Los Angeles, California
    Rand Schrader Health and Research Clinic
Apr 27, 2021

Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia Trial in Bergamo (Blinatumomab Expanded T-cells (BET))

Active, not recruiting
  • Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
  • Blinatumomab Expanded T-cells (BET)
  • Bergamo, Italy
    ASST - Papa Giovanni XXIII
Dec 22, 2021

HIV/AIDS Trial in Guangzhou (CAR-T cells)

Recruiting
  • HIV/AIDS
  • CAR-T cells
  • Guangzhou, Guangdong, China
    Guangzhou 8th People's Hospital
Jul 19, 2021

SCID Trial in United States (Humanized anti-CD117 Monoclonal Antibody (JSP191))

Recruiting
  • SCID
  • Humanized anti-CD117 Monoclonal Antibody (JSP191)
  • Los Angeles, California
  • +7 more
Nov 16, 2021

Pediatric Patients, Any Type of Severe Combined Immunodeficiency (SCID), Partial HLA Incompatible Allogeneic Hematopoietic Stem

Recruiting
  • Pediatric Patients
  • +2 more
  • Human T Lymphoid Progenitor (HTLP) injection
  • Paris, Ile De France, France
    Unité d'Immunologie Hématologie Rhumatologie Pédiatrique (UIHR),
Apr 13, 2021

Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
Oct 25, 2021

Recurrent Melanoma, Stage IV Melanoma Trial in Rochester (drug, other, procedure)

Completed
Has Results
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Rochester, Minnesota
    Mayo Clinic
Sep 28, 2020